Literature DB >> 16564238

Ethics guidelines for destination therapy.

Denise M Dudzinski1.   

Abstract

The introduction of the left ventricular assist device as a destination therapy for patients with heart failure introduces several ethical issues. These issues are discussed to help destination therapy teams design ethically sound policies and procedures. This article addresses ethical issues pertaining to informed decision making, device failure, and change out, as well as guidelines for deactivation, fair employment of medical and psychosocial criteria, the nature of destination therapy as an elective end-of-life therapy, and advance care planning strategies.

Entities:  

Mesh:

Year:  2006        PMID: 16564238     DOI: 10.1016/j.athoracsur.2005.11.002

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

Review 1.  Palliative care and end-of-life issues in patients treated with left ventricular assist devices as destination therapy.

Authors:  Keith M Swetz; Abigale L Ottenberg; Monica R Freeman; Paul S Mueller
Journal:  Curr Heart Fail Rep       Date:  2011-09

Review 2.  Ethical dilemmas surrounding the use of ventricular assist devices in supporting patients with end-stage organ dysfunction.

Authors:  Courtenay R Bruce; Baruch Brody; Mary A Majumder
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

Review 3.  Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices.

Authors:  Nancy Luo; Joseph G Rogers; Gwen C Dodson; Chetan B Patel; Anthony N Galanos; Carmelo A Milano; Christopher M O'Connor; Robert J Mentz
Journal:  Am J Cardiol       Date:  2016-06-21       Impact factor: 2.778

Review 4.  Ethical challenges of deactivation of cardiac devices in advanced heart failure.

Authors:  Hassan Chamsi-Pasha; Mohammed A Chamsi-Pasha; Mohammed Ali Albar
Journal:  Curr Heart Fail Rep       Date:  2014-06

5.  Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy.

Authors:  Keith M Swetz; Monica R Freeman; Omar F AbouEzzeddine; Kari A Carter; Barry A Boilson; Abigale L Ottenberg; Soon J Park; Paul S Mueller
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

6.  End-of-life discontinuation of destination therapy with cardiac and ventilatory support medical devices: physician-assisted death or allowing the patient to die?

Authors:  Mohamed Y Rady; Joseph L Verheijde
Journal:  BMC Med Ethics       Date:  2010-09-15       Impact factor: 2.652

Review 7.  Life-saving devices reach the end of life with heart failure.

Authors:  Daniel D Matlock; Lynne Warner Stevenson
Journal:  Prog Cardiovasc Dis       Date:  2012 Nov-Dec       Impact factor: 8.194

Review 8.  LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant.

Authors:  Anne K Eshelman; Shawn Mason; Hassan Nemeh; Celeste Williams
Journal:  Heart Fail Rev       Date:  2008-01-24       Impact factor: 4.214

9.  Ethical challenges with the left ventricular assist device as a destination therapy.

Authors:  Aaron G Rizzieri; Joseph L Verheijde; Mohamed Y Rady; Joan L McGregor
Journal:  Philos Ethics Humanit Med       Date:  2008-08-11       Impact factor: 2.464

10.  Matters to address prior to introducing new life support technology in Japan: three serious ethical concerns related to the use of left ventricular assist devices as destination therapy and suggested policies to deal with them.

Authors:  Atsushi Asai; Sakiko Masaki; Taketoshi Okita; Aya Enzo; Yasuhiro Kadooka
Journal:  BMC Med Ethics       Date:  2018-02-27       Impact factor: 2.652

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.